Tag Archives: Deals

M&A Round-up • 3/25/2009

By George Koroneos | Published: March 25, 2009
The latest round of merger and acquisition activities courtesy of our friends at Pharm Exec Europe: • Just days after its purchase of Genentech, Roche has made another acquisition, albeit a much smaller one, of the German firm Innovatis. Roche will pay EUR 15 million for the cell analytics company. • Oxford Gene Technology (OGT) is to [...]
Posted in Deals | Also tagged , , , , , , , , , | Leave a comment

Pfizer to Buy Wyeth for $68 Billion

By George Koroneos | Published: January 26, 2009
Pfizer made it official this morning. The pharma giant acquired Wyeth for $50.19 a share or $68 billion in cash and stocks, and news of the merger sent ripples through the pharma industry: Pfizer Broadens Beyond Pills with $68 Billion Wyeth Buy: Pfizer has agreed to acquire Wyeth in a $68 billion deal that’s the largest [...]
Posted in Deals | Also tagged , , , | Leave a comment

What a Week! Roche and Genentech … and Mirus!?!

By Walter Armstrong | Published: July 25, 2008
The big news this week—and, for that matter, this year—is Roche’s offer to buy the 44 percent of Genentech that it doesn’t already own. The blogosphere is burning with all the predictable predictions, dire and otherwise, attendant on a big pharma takeover of a biotech. The phrase “killing the goose that’s been laying the golden [...]
Posted in Biotech, Deals, Gene therapy, R&D, Strategy, Technology | Also tagged , , , , | 1 Comment